kainic acid has been researched along with Parkinson Disease, Secondary in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bourke, D; Finkelstein, DI; Henderson, JM; Horne, MK; Patch, J; Stanic, D; Tomas, D | 1 |
Belzunegui, S; Garrido, P; Guillén, J; Izal, A; Luquin, MR; Saldise, L; San Sebastián, W; Vázquez, M | 1 |
Kresiun, VI; Mazarati, AM; Servetskiĭ, KL; Shandra, AA | 1 |
Chiang, YH; Wang, Y; Zhou, FC | 1 |
Imai, H; Inase, M; Kojima, J; Matsumura, M; Nambu, A; Takada, M; Tokuno, H; Yamaji, Y | 1 |
Corthesy, ME; Cummins, A; Lieberman, DM; Oldfield, EH | 1 |
Aziz, TZ; Munro-Davies, LE; Stein, JF; Winter, J | 1 |
Godlevskiĭ, LS; Kryzhanovskiĭ, GN; Makul'kin, RF; Rozhkov, VS; Shandra, AA | 1 |
8 other study(ies) available for kainic acid and Parkinson Disease, Secondary
Article | Year |
---|---|
Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys.
Topics: Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Callithrix; Cell Count; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Agonists; Female; Functional Laterality; Immunohistochemistry; Kainic Acid; Male; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Posture; Psychomotor Performance; Reaction Time; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |
Does increased excitatory drive from the subthalamic nucleus contribute to dopaminergic neuronal death in Parkinson's disease?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Cell Count; Cell Death; Dopamine; Immunohistochemistry; Kainic Acid; Macaca fascicularis; Neurons; Parkinson Disease, Secondary; Subthalamic Nucleus; Tyrosine 3-Monooxygenase | 2006 |
[The effect of galanin on the experimental parkinsonian syndrome in rats induced by the intrastriatal administration of kainic acid].
Topics: Animals; Behavior, Animal; Caudate Nucleus; Corpus Striatum; Dose-Response Relationship, Drug; Drug Synergism; Galanin; Kainic Acid; Male; Microinjections; Neuropeptides; Parkinson Disease, Secondary; Peptides; Rats; Rats, Wistar; Time Factors | 1993 |
Constructing a new nigrostriatal pathway in the Parkinsonian model with bridged neural transplantation in substantia nigra.
Topics: Animals; Behavior, Animal; Cell Division; Dopamine; Excitatory Amino Acid Agonists; Female; Fetal Tissue Transplantation; Horseradish Peroxidase; Immunohistochemistry; Kainic Acid; Neostriatum; Nerve Growth Factors; Neural Pathways; Neurons; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra; Transplantation, Heterotopic | 1996 |
Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey.
Topics: Animals; Choline O-Acetyltransferase; Female; Functional Laterality; Kainic Acid; Macaca; Male; Microinjections; Neurons; Neurotoxins; Parkinson Disease, Secondary; Pons | 1997 |
Reversal of experimental parkinsonism by using selective chemical ablation of the medial globus pallidus.
Topics: Animals; Drug Evaluation, Preclinical; Feasibility Studies; Globus Pallidus; Ibotenic Acid; Infusions, Intra-Arterial; Infusions, Parenteral; Kainic Acid; Macaca mulatta; MPTP Poisoning; Parkinson Disease, Secondary; Stereotaxic Techniques | 1999 |
The role of the pedunculopontine region in basal-ganglia mechanisms of akinesia.
Topics: Alfaxalone Alfadolone Mixture; Animals; Basal Ganglia; Behavior, Animal; Excitatory Amino Acid Agonists; Female; Hypokinesia; Kainic Acid; Macaca mulatta; Male; Neural Pathways; Parkinson Disease, Secondary; Pons | 1999 |
[Modelling of the parkinsonian syndrome by the administration of kainic acid into the caudate nucleus].
Topics: Animals; Caudate Nucleus; Disease Models, Animal; Drug Evaluation, Preclinical; Electrodes, Implanted; Electroencephalography; Female; Injections; Kainic Acid; Levodopa; Male; Parkinson Disease, Secondary; Rats; Time Factors; Trihexyphenidyl | 1987 |